[Stress and neurodegeneration: pharmacologic strategies].
Long-term exposure to stress has detrimental effects on several brain functions in many species, including humans and leads to neurodegenerative changes. However, the underlying neural mechanisms by which stress causes neurodegeneration are still unknown. We have investigated the role of endogenously released nitric oxide (NO) in this phenomenon and the possible induction of inducible NO synthase (iNOS) isoform. In adult male rats, stress (immobilisation for 6 h during 21 days) increases the activity of a calcium-independent NOS and induces the expression of iNOS in cortical neurons as seen by immunohistochemical and Western blot analysis. Three weeks of repeated immobilisation increases immunoreactivity for nitrotyrosine, a nitration product of peroxynitrate. Repeated stress causes NO2(-) + NO3- (NOx) accumulation in cortex, and these changes occurs in parallel with lactate dehydrogenase (LDH) release and impairment of glutamate uptake in synaptosomes. The administration of the preferred iNOS inhibitor aminoguanidine (400 mg/kg i.p. daily from days 7 to 21 of stress) prevents NOx- accumulation in cortex, LDH release and impairment of glutamate uptake in synaptosomes, as well as other markers of oxidative stress such as lipid peroxidation and decrease in glutation. Taken together, these findings indicate that a sustained overproduction of nitric oxide via iNOS expression may be responsible, at least in part, of some of the neurodegenerative changes caused by stress, and support a possible neuro-protective role for specific iNOS inhibitors in this situation.